|4May 27, 7:00 PM ET

Pavell Jeff 4

4 · Silo Pharma, Inc. · Filed May 27, 2025

Insider Transaction Report

Form 4
Period: 2025-05-23
Pavell Jeff
Director
Transactions
  • Award

    Options (right to buy)

    2025-05-23+50,00050,000 total
    Exercise: $0.43From: 2026-05-23Exp: 2035-05-23Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary